Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography–electrospray ionization mass spectrometry
- 1 October 2000
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 748 (1) , 113-123
- https://doi.org/10.1016/s0378-4347(00)00292-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Enantioselective determination of propafenone and its metabolites in human plasma by liquid chromatography–mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Identification and determination of phase I metabolites of propafenone in rat liver perfusateJournal of Pharmaceutical and Biomedical Analysis, 1998
- An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy.Circulation, 1994
- PropafenoneDrugs, 1993
- Identification and determination of propafenone and its principal metabolites in human urine using capillary gas chromatography/mass spectrometryJournal of Mass Spectrometry, 1991
- In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenoneClinical Pharmacology & Therapeutics, 1989
- Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.Circulation, 1987
- Clinical pharmacology of propafenone: Pharmacokinetics, metabolism and concentration-response relationsThe American Journal of Cardiology, 1984